COMPANY OVERVIEW

 

Mount Tam Biotechnologies is a specialty biopharmaceutical company formed to develop, optimize and bring to market leading medical compounds to better the health and well-being of millions of people who have been affected by autoimmune diseases. The organization's most advanced product, TAM-01, focuses on the treatment of systemic lupus erythematosus (SLE) - the most common form of lupus. 

 

To successfully lead through clinical development, Mount Tam has assembled an experienced management team, multiple advisory boards and is working extensively with the world-renowned Buck Institute for Research on Aging based in Northern California. It has an exclusive worldwide licensing and collaboration agreement with the Buck Institute, which includes some of the Institute’s first R&D assets in the area of autoimmune disorders. The licensed assets are supported by an extensive portfolio of intellectual property consisting of over 45 worldwide issued patents and patent applications, including composition-of-matter, manufacturing and therapeutic-area applications. 

 

Learn more about the team that continues to push all aspects of Mount Tam forward, helping to advance therapeutics for autoimmune diseases.